Home LiteratureArticle Details
PMID: 11287644 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing.

Surman S, Lockey TD, Slobod KS, Jones B, Riberdy JM, White SW, Doherty PC, Hurwitz JL

Abstract

The spectrum of immunogenic epitopes presented by the H2-IA(b) MHC class II molecule to CD4(+) T cells has been defined for two different (clade B and clade D) HIV envelope (gp140) glycoproteins. Hybridoma T cell lines were generated from mice immunized by a sequential prime and boost regime with DNA, recombinant vaccinia viruses, and protein. The epitopes recognized by reactive T cell hybridomas then were characterized with overlapping peptides synthesized to span the entire gp140 sequence. Evidence of clonality also was assessed with antibodies to T cell receptor Valpha and Vbeta chains. A total of 80 unique clonotypes were characterized from six individual mice. Immunogenic peptides were identified within only four regions of the HIV envelope. These epitope hotspots comprised relatively short sequences ( approximately 20-80 aa in length) that were generally bordered by regions of heavy glycosylation. Analysis in the context of the gp120 crystal structure showed a pattern of uniform distribution to exposed, nonhelical strands of the protein. A likely explanation is that the physical location of the peptide within the native protein leads to differential antigen processing and consequent epitope selection.

MeSH Terms
Amino Acid Sequence Animals CD4-Positive T-Lymphocytes/immunology Epitopes/chemistry,immunology Female Gene Products, env/chemistry,immunology HIV Antigens/chemistry,immunology Mice Mice, Inbred C57BL Models, Molecular Molecular Sequence Data Sequence Homology, Amino Acid env Gene Products, Human Immunodeficiency Virus
Chemicals
Epitopes Gene Products, env HIV Antigens env Gene Products, Human Immunodeficiency Virus gp140 envelope protein, Human immunodeficiency virus 1
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Surman S
Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Lockey T D
Slobod K S
Jones B
Riberdy J M
White S W
Doherty P C
Hurwitz J L
References (55)
55 references, click to expand
  1. Identification of T-cell epitopes without B-cell activity in the first and second conserved regions of the HIV Env protein.
    AIDS. 1991 Jun;5(6):699-707 PMID: 1715718
  2. Complete nucleotide sequence of the AIDS virus, HTLV-III.
    Nature. 1985 Jan 24-30;313(6000):277-84 PMID: 2578615
  3. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation.
    Immunol Rev. 1999 Dec;172:121-9 PMID: 10631942
  4. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice.
    J Immunol. 1995 Oct 15;155(8):3964-71 PMID: 7561104
  5. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.
    J Virol. 1994 Jan;68(1):469-84 PMID: 7504741
  6. Polyadenylylation of sea urchin histone RNA sequences in transfected COS cells.
    Proc Natl Acad Sci U S A. 1985 Feb;82(4):1094-8 PMID: 2858095
  7. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection.
    J Virol. 1996 Dec;70(12):8375-81 PMID: 8970958
  8. T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region.
    J Immunol. 1999 Jan 1;162(1):568-76 PMID: 9886434
  9. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
    J Virol. 1994 Dec;68(12):8056-63 PMID: 7966595
  10. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation.
    Nature. 1998 Dec 17;396(6712):695-9 PMID: 9872320
  11. Comprehensive T-cell epitope mapping of HIV-1 env antigens reveals many areas recognized by HIV-1-seropositive and by low-risk HIV-1-seronegative individuals.
    J Acquir Immune Defic Syndr. 1994 Sep;7(9):879-90 PMID: 7519672
  12. HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. WHO Network for HIV Isolation and Characterization.
    AIDS Res Hum Retroviruses. 1994 Nov;10(11):1327-43 PMID: 7545977
  13. HIV type 1 envelope sequence diversity in inner city community.
    AIDS Res Hum Retroviruses. 1994 Jul;10(7):873-5 PMID: 7986592
  14. Qualitative and quantitative studies of antigen-presenting cell function by using I-A-expressing L cells.
    J Immunol. 1985 Nov;135(5):2914-22 PMID: 3900200
  15. Viral immune evasion due to persistence of activated T cells without effector function.
    J Exp Med. 1998 Dec 21;188(12):2205-13 PMID: 9858507
  16. HIV-1 peptides induce a proliferative response in lymphocytes from infected persons.
    J Acquir Immune Defic Syndr. 1989;2(5):448-56 PMID: 2552068
  17. A synthetic peptide from the first conserved region in the envelope protein gp160 is a strong T-cell epitope in HIV-infected chimpanzees and humans.
    Viral Immunol. 1998;11(3):147-58 PMID: 9918406
  18. Help for cytotoxic-T-cell responses is mediated by CD40 signalling.
    Nature. 1998 Jun 4;393(6684):478-80 PMID: 9624004
  19. CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma.
    Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5135-40 PMID: 10220431
  20. MHC ligands and peptide motifs: first listing.
    Immunogenetics. 1995;41(4):178-228 PMID: 7890324
  21. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans.
    Nature. 1988 Aug 25;334(6184):706-8 PMID: 2457809
  22. Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus.
    J Immunol. 2000 Feb 15;164(4):1820-8 PMID: 10657630
  23. Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1.
    Clin Exp Immunol. 1992 Jan;87(1):37-45 PMID: 1370773
  24. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands.
    J Virol. 1992 Apr;66(4):1977-84 PMID: 1312614
  25. A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation.
    Vaccine. 1999 Mar 17;17(11-12):1567-72 PMID: 10195794
  26. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses.
    J Exp Med. 1998 Dec 21;188(12):2199-204 PMID: 9858506
  27. Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides.
    J Immunol. 1999 Apr 1;162(7):4030-6 PMID: 10201925
  28. Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinants.
    Vaccine. 1997 Feb;15(3):265-72 PMID: 9139484
  29. Establishment and characterization of human immunodeficiency virus type 1 (HIV-1) envelope-specific CD4+ T lymphocyte lines from HIV-1-seropositive patients.
    J Infect Dis. 1995 Jun;171(6):1420-30 PMID: 7769275
  30. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice.
    Cell Immunol. 1991 Mar;133(1):234-52 PMID: 1671342
  31. Two better cell lines for making hybridomas expressing specific T cell receptors.
    J Immunol. 1989 Sep 15;143(6):1822-5 PMID: 2778316
  32. The immune response of BALB/c mice to influenza hemagglutinin: commonality of the B cell and T cell repertoires and their relevance to antigenic drift.
    Eur J Immunol. 1989 Mar;19(3):515-21 PMID: 2540011
  33. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.
    Science. 1998 Jun 19;280(5371):1884-8 PMID: 9632381
  34. The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype.
    J Exp Med. 1984 Aug 1;160(2):452-71 PMID: 6206178
  35. The antigenic structure of the HIV gp120 envelope glycoprotein.
    Nature. 1998 Jun 18;393(6686):705-11 PMID: 9641684
  36. T cell multideterminant regions in the human immunodeficiency virus envelope: toward overcoming the problem of major histocompatibility complex restriction.
    Int Immunol. 1989;1(4):409-15 PMID: 2484961
  37. Peptide exchange in MHC molecules.
    Immunol Rev. 1999 Dec;172:229-38 PMID: 10631949
  38. Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response.
    J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jul;12(3):213-20 PMID: 8673525
  39. Effect of natural HIV-1 envelope V1-V2 sequence diversity on the binding of V3-specific and non-V3-specific antibodies.
    J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Oct 1;16(2):69-73 PMID: 9358100
  40. Get into the groove! Targeting antigens to MHC class II.
    Immunol Rev. 1999 Dec;172:87-96 PMID: 10631939
  41. Does the key to a successful HIV type 1 vaccine lie among the envelope sequences of infected individuals?
    AIDS Res Hum Retroviruses. 1995 Sep;11(9):1131-3 PMID: 8554911
  42. LacZ inducible, antigen/MHC-specific T cell hybrids.
    Int Immunol. 1994 Mar;6(3):369-76 PMID: 8186188
  43. Raster3D: photorealistic molecular graphics.
    Methods Enzymol. 1997;277:505-24 PMID: 18488322
  44. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.
    J Exp Med. 1981 May 1;153(5):1198-214 PMID: 6166712
  45. Roles of alpha beta and gamma delta T cell subsets in viral immunity.
    Annu Rev Immunol. 1992;10:123-51 PMID: 1534240
  46. Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting.
    Virology. 1997 Apr 14;230(2):265-74 PMID: 9143282
  47. Mechanisms and consequences of peptide selection by the I-Ak class II molecule.
    Immunol Rev. 1999 Dec;172:209-28 PMID: 10631948
  48. High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment.
    Virology. 2000 Apr 10;269(2):313-24 PMID: 10753710
  49. Characteristics of the influenza virus-specific CD8+ T cell response in mice homozygous for disruption of the H-2lAb gene.
    J Immunol. 1995 Sep 15;155(6):2955-9 PMID: 7673713
  50. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
    J Immunol. 1994 May 15;152(10):4893-902 PMID: 8176210
  51. Intracellular traffic to compartments for MHC class II peptide loading: signals for endosomal and polarized sorting.
    Immunol Rev. 1999 Dec;172:171-87 PMID: 10631946
  52. Requirement for cotolerogenic gene products in the clonal deletion of I-E reactive T cells.
    Science. 1990 Feb 23;247(4945):964-7 PMID: 1968289
  53. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
    J Immunol. 1994 Jan 15;152(2):549-56 PMID: 8283036
  54. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.
    Nature. 1991 May 23;351(6324):290-6 PMID: 1709722
  55. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies.
    J Virol. 1997 Oct;71(10):7719-27 PMID: 9311856
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2001-04-10
Epub
2001-00-03
Pages
4587-92
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC31878
Subset
IM
Grants
NIAID NIH HHS · P01 AI045142 · United States
NCI NIH HHS · P30 CA021765 · United States
NIAID NIH HHS · P01-AI45142 · United States
NCI NIH HHS · P30-CA21765 · United States
Databases
GENBANK
AF321563, AF338704
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com